Australia Seeks Views On Revised National Medicines Policy
As part of its ongoing review of the National Medicines Policy, Australia’s Department of Health calls for “robust and transparent prioritization of spending on medicines” as well as a collective approach to ensuring speedy and equitable access to affordable medicines for all communities.
You may also be interested in...
Stakeholders are being asked to say what they think of plans to future-proof the framework that governs access to medicines and is intended to help bolster the pharmaceutical sector.
As talks restart this week on a future pandemic accord, the international drug industry body, the IFPMA, has reiterated its concerns over the negotiating text, saying some measures could “severely hinder responses to future pandemics.”
The new committee, which will initially be in place for a year, will advise the French drug regulator when it is preparing its opinions on substitution in specific biosimilar product groups.